omeprazole and bromazepam

omeprazole has been researched along with bromazepam in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (85.71)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	2
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Berger-Gryllaki, M; Buclin, T; Pannatier, A; Podilsky, G; Roulet, M; Testa, B	1

Trials

1 trial(s) available for omeprazole and bromazepam

Article	Year
The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube. European journal of clinical pharmacology, 2009, Volume: 65, Issue:5 Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Bromazepam; Cohort Studies; Cross-Over Studies; Female; Half-Life; Humans; Intubation, Gastrointestinal; Male; Metabolic Clearance Rate; Omeprazole; Prospective Studies; Reproducibility of Results; Therapeutic Equivalency	2009

Article

Year

The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.

European journal of clinical pharmacology, 2009, Volume: 65, Issue:5

Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Anti-Ulcer Agents; Area Under Curve; Biological Availability; Bromazepam; Cohort Studies; Cross-Over Studies; Female; Half-Life; Humans; Intubation, Gastrointestinal; Male; Metabolic Clearance Rate; Omeprazole; Prospective Studies; Reproducibility of Results; Therapeutic Equivalency

2009

Other Studies

6 other study(ies) available for omeprazole and bromazepam

Article	Year
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15 Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water	2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13 Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding	2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010